Vivos Therapeutics logo

Vivos Therapeutics

VVOS | NASDAQ
Chart Builder DCF Calculator
$0.50
-$0.01 (-2.19%)
At close: Jun 18, 2026, 4:00 PM ET
-2.19%

Rating

Updated: May 9, 2026
21
Fundamentals Weak
Market Sentiment Bearish
Moat None

Key Statistics

Market Data

Market Cap $2.94M
1D Range
0.45 0.52
52W Range
0.45 7.95

Valuation (TTM)

PE -0.22
PB -2.59
EV/EBITDA -0.57

Valuation (NTM)

Forward PE N/A
Forward PEG N/A
Price Target $2.13
Loading financial charts...

Profile

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in ad...

Sector Healthcare
Employees 109
IPO Date Dec 11, 2020
Website vivos.com
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
May 20, 2026
EPS
-$0.52
Miss -15.56%
REV
$5.14M
Beat +18.22%
Earnings Details ➞

Analyst Summary

# of Analysts
2
Consensus
Buy
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.